跳至主要内容
临床试验/NCT07432360
NCT07432360招募中不适用

Bridging Imaging and Pathology: Using Advanced MRI Protocols in Correlation With Extensive Histopathology to Detect Clinically Significant Prostate Cancer

Virdx, Inc.1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年1月28日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
Comparison of different microstructure models in the performance of detecting csPCa

研究概览

简要总结

In recent years, new and promising approaches have emerged in the field of MRI imaging of the prostate. These approaches usually aim to visualise the so-called "microstructures" of the tissue and are intended to offer greater accuracy in the diagnosis of prostate cancer than the current mpMRI examination. To this end, mathematical microstructure models are calculated that determine the proportional presence of histological substructures in specific MRI volumes. Additional new MRI sequences that are not routinely recorded are required to calculate the microstructure models. In order to further investigate the possibilities of these new MRI sequences, this study will compare different mathematical models. In addition, a histopathological examination of the tissue will be performed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Humans with a prostate ≥18 years of age.
  • Patients with biopsy-proven PCa who are scheduled for an RPE.
  • Signed informed consent form (ICF) that demonstrates study participant understands the purpose of and procedures necessary for the study.
  • Willingness, ability, and legal capacity to participate in the study.
  • Ability to adhere to the prohibitions and restrictions defined in this protocol.

排除标准

  • Inability to give consent.
  • Prior hormone treatment (i.e., androgen deprivation treatment (ADT) and/or 5-ɑ-reductase inhibitors).
  • Prior PCa treatment.
  • Prior transurethral resection of the prostate (TUR-P) or other prostate surgery.
  • Prior total hip arthroplasty on one or both sides or other metal implants that interfere with the MRI acquisition of the hip region.
  • General contraindications for an MRI scan (i.e., pacemaker, relevant metal implants, etc.).

研究组 & 干预措施

Patients with biopsy-proven PCa who are scheduled for RPE

结局指标

主要结局

Comparison of different microstructure models in the performance of detecting csPCa

时间窗: Upon study completion since data from all subjects need to be included (Until 6 months after the last patient got included)

次要结局

未报告次要终点

研究者

发起方
Virdx, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验